Donepezil for Irradiated Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled Clinical Trial
Donepezil (Aricept) is a drug approved for Alzheimer's disease. This study shows that it might be beneficial for brain tumor patients who have had brain radiation. It may even help people who already have deficits.
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://jco.ascopubs.org/content/early/2015/04/15/JCO.2014.58.4508?cmpid=jco_pap_20Apr2015
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines